Skip to main content

Medical Technology Innovator Thornhill Medical’s MOVES® SLC™ is acquired for United States Marine Corp En Route Care Modernization and added to Authorized Medical Allowance List (AMAL) 647

Written by Customer Service on . Posted in Mergers And Acquisitions.

TORONTO, Dec. 06, 2023 (GLOBE NEWSWIRE) — Medical technology innovator Thornhill Medical is pleased to announce that the United States Marine Corps (USMC) has acquired its integrated life support technology, MOVES® SLC™. The acquisition supports USMC En Route Care modernization goals using state-of-the-art, lightweight, critical care equipment to successfully transport patients from Role 2 to Role 3 care. MOVES® SLC™ has also been formally added to the U.S. Marine Corps’ Authorized Medical Allowance List (AMAL) 647 for En Route Care.

The game-changing MOVES® SLC™ system addresses the need for medical technology that is smaller, lighter, more durable, flexible and easy to maintain, and less reliant on supply chain. This enables care of wounded Marines with advanced critical care capabilities in far forward, extreme or austere environments, sustaining care over lengthy evacuation distances, with a variety of transportation modes.

MOVES® SLC™ is the only micro-integrated life support system that combines an oxygen (O2) concentrator, a unique O2-conserving ventilator, suction, and complete vital signs monitoring in a single compact, rugged, portable, battery-operated system, which operates without oxygen cylinders.

Thornhill Medical’s first generation of MOVES® technology was developed specifically for the needs of the USMC. Since that time, the transformative technology has been making a remarkable impact in the delivery of care and transport of trauma patients in current real-world combat and humanitarian missions.

“This latest AMAL approval and modernization purchase of the MOVES® SLC™ technology reaffirms that Thornhill Medical will continue to support the USMC, the US military more broadly and others around the world to be future-ready now, in an evolving battle space,” says Derek Watt, VP Field Operations, Thornhill Medical.

“Mobility and logistic efficiency will overwhelmingly influence the ability of military medicine to accomplish its mission and save lives,” explains Thornhill Medical Military Advisory Council Member and former US Navy Surgeon General, VADM (Dr.) Forrest Faison (US Navy, Ret) “Innovative medical technologies built for battlefields like Thornhill Medical’s MOVES® SLC™ delivers on both mobility and reducing logistic support requirements to allow medical teams to deliver the latest and best technologies for casualty care anywhere, at any time, and to sustain that capability throughout the conflict.”

For more information, please contact:

Kathleen Powderley
416-803-5597
Kathleen@responsiblecomm.ca

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.